Primary Record
Ibipinabant
- In stock
- 5,586 g
- Purity
- 98.6 %
- CAS
- 362519-49-1
Compound Identifiers & Properties
- CAS
- 362519-49-1
- PubChem CID
- 11179267
- SMILES
- CN=C(NS(=O)(=O)C1=CC=C(C=C1)Cl)N2CC(C(=N2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4
- Canonical SMILES
- CN=C(NS(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1
Names & Synonyms
- Ibipinabant
- 362519-49-1
- ()-Ibipinabant
- RAC-IBIPINABANT
- (+/-)-Ibipinabant
- (+/-)-SLV 319
- ((plusmn))-SLV319
- SLV319
- SLV-319 Racemic
- RefChem:931856
- C23H20Cl2N4O2S
- SLV-319
- CHEMBL158784
- SLV 319
- orb1302681
- R-SLV319
- SCHEMBL1315229
- SCHEMBL1951000
- SCHEMBL1951003
- SCHEMBL3679986
- ( inverted exclamation markA)-Ibipinabant
- SCHEMBL14740149
- ( inverted exclamation markA)-SLV319
- BDBM29094
- CTK8E8422
- DTXSID60457819
- ( inverted exclamation markA)-SLV 319
- rac-(+/-)-SLV 319
- (Inverted exclamation markA)-SLV319
- GLXC-10758
- HMS3650M14
- (+/-)-SLV319(Ibipinabant)?
- (R)-SLV 319
- (S)-SLV 319
- BCP30069
- EX-A3299
- GBB82786
- 1056AH
- BDBM50230411
- HY-14791A
- MFCD12912330
- MFCD28133367
- ZB0029
- 3-(4-Chlorophenyl)-N-((4-chlorophenyl)sulfonyl)-N'-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide
- AKOS024458248
- AKOS037515616
- CS-6430
- CID 9826744
- CID11179267
- ( inverted exclamation markA)-SLV-319
- (R)-(+)-SLV 319
- ( )-SLV 319
- (+/-)-SLV319
- AC-35678
- AK555637
- BS-17130
- ()-SLV319;()-BMS6462
- RT-015587
- D83785
- A934981
- BMS 646256; SLV 319;JD 5001;Ibipinabant
- C482795
- SR-01000946306
- SR-01000946306-1
- (+/-)-SLV319;(+/-)-BMS6462
- B0084-112540
- 464213-10-3
- 5-(4-chlorophenyl)-N-(4-chlorophenyl)sulfonyl-N'-methyl-4-phenyl-3,4-dihydropyrazole-2-carboximidamide
- 656827-86-0
- (E)-3-(4-chlorophenyl)-N-((4-chlorophenyl)sulfonyl)-N'-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide
- 5-(4-chlorophenyl)-N-(4-chlorophenyl)sulfonyl-N//'-methyl-4-phenyl-3,4-dihydropyrazole-2-carboximidamide
- ( inverted exclamation markA)-Ibipinabant;( inverted exclamation markA)-BMS646256
- ( inverted exclamation markA)-BMS-646256; ( inverted exclamation markA)-BMS646256; ( inverted exclamation markA)-BMS 646256; ( inverted exclamation markA)-SLV-319; ( inverted exclamation markA)-SLV 319; SLV319; ( inverted exclamation markA)-JD-5001; ( inverted exclamation markA)-JD 5001; ( inverted exclamation markA)-JD5001; ( inverted exclamation markA)-Ibipinabant
- (4R)-3-(4-Chlorophenyl)-N-[(4-chlorophenyl)sulfonyl]-4,5-dihydro-N'-methyl-4-phenyl-1H-pyrazole-1-carboximidamide
- (R)-(+)-3-(4-chlorophenyl)-N'-(4-chlorophenylsulfonyl)-N-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide
- (S)-3-(4-chlorophenyl)-N-(4-chlorophenylsulfonyl)-N'-methyl-4-phenyl-4,5-dihydropyrazole-1-carboxamidine
- 3-(4-chlorophenyl)-N''''''''-(4-chlorophenylsulfonyl)-N-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide
- 3-(4-chlorophenyl)-N'-(4-chlorophenylsulfonyl)-N-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide
- 3-(4-Chlorophenyl)-N-[(4-Chlorophenyl)sulfonyl]-4,5-dihydro-N'-methyl-4-phenyl-1H-pyrazole-1-carboximidamide
- 3-(4-Chlorophenyl)-N-[(4-Chlorophenyl)Sulfonyl]-4,5-Dihydro-N-Methyl-4-Phenyl-1H-Pyrazole-1-Carboximidamide
- 3-(4-Chlorophenyl)-N-[(4-chlorophenyl)sulfonyl]-4,5-dihydro-Na(2)-methyl-4-phenyl-1H-pyrazole-1-carboximidamide
- 3-(4-chlorophenyl)-n-methyl-n'-((4-chlorophenyl)sulfonyl)-4-phenyl-4,5-dihydro-1h-pyrazole-1-carboxamidine
- 4-Chloro-N-[1-[3-(4-chloro-phenyl)-4-phenyl-4,5-dihydro-pyrazol-1-yl]-1-methylamino-meth-(E)-ylidene]-benzenesulfonamide
- 5-(4-Chlorophenyl)-N-(4-chlorophenyl)sulfonyl-N"-methyl-4-phenyl-3,4-dihydropyrazole-2-carboximidamide
- 5-(4-chlorophenyl)-N-(4-chlorophenyl)sulfonyl-N'-methyl-4-phenyl-3,4-dihydropyrazole-2-carboxamidine
- N-(4-Chlorobenzene-1-sulfonyl)-3-(4-chlorophenyl)-N'-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide
- N-(4-chlorobenzenesulfonyl)-3-(4-chlorophenyl)-N'-methyl-4-phenyl-4,5-dihydropyrazole-1-carboximidamide